{"name":"NantCell, Inc.","slug":"nantcell-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ad5 CEA Vaccine","genericName":"Ad5 CEA Vaccine","slug":"ad5-cea-vaccine","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Ad5 CEA Vaccine","genericName":"Ad5 CEA Vaccine","slug":"ad5-cea-vaccine","phase":"phase_1","mechanism":"An adenoviral vector-based vaccine that delivers the CEA gene to stimulate immune responses against CEA-expressing cancer cells.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOeHhDVUdFSjdaUU9JY3dTUEdUWWxvdWZzOGxCOHZrc081RkI3RExWU29JVDFlakswcFhDdUNKU3hZZThJbFgyczlpUldRei1GQ0ZqLVZ5TjZEdWRfM045N21XcEVkd0M5V3ZYZFEzTDBFVWdmQTNEY0UzQXVJX0kteFRkbkdnTlpldktRbV8taTNMQmJQQy1SdTBDSEpFUmEwQ0MyOHBiMGl3RVZ3TUtlVVVkb3FRcWVkTkl0c1dpdnpJdGVfM2RMZA?oc=5","date":"2024-04-23","type":"regulatory","source":"Seeking Alpha","summary":"ImmunityBio: Anktiva Approval Opens Up A World Of Possibilities, Risks And Potential Gains - Seeking Alpha","headline":"ImmunityBio: Anktiva Approval Opens Up A World Of Possibilities, Risks And Potential Gains","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQWkJreXBzZUtsWVBaMGxVZTB6X1ZmZ3JBMFJtdjJSQW1COXJvSXpuMjJaeWRYeG9hVlgzSTVNeldtS3piSUlEbVlJQVhkcTgtQlpmRGI1RzIyZjBDcWFTUTZaUzl4NDVSN1Vwd2plcTloaDlxaHB1QXFPenBQR1V6R0p4SGZyaV9jN0FYQU9lY1pJcjJEZ3JLcmJNSi1ReHZNTXc2Q3AyX2p6cjVH?oc=5","date":"2023-02-13","type":"deal","source":"Fierce Biotech","summary":"3 years after rejecting $1B buyout, Sorrento files for bankruptcy amid legal battles - Fierce Biotech","headline":"3 years after rejecting $1B buyout, Sorrento files for bankruptcy amid legal battles","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOOUhZbUpLbXp4ODhheDhLLWVJdkNDMERoazkxTlE2V2NUSFVFcmFaemR4WkJQbmdvdDlaa1pnNFpMOHR6V285RFoyWHJOdzZrZkxzWGN6eXRxQkQyOGJoZVhYaGlzSmgtVlExeVlHdjVUNm9sMHpFNVNKSnhfRHl6NkdQN3F0RUFxYUFhaEFWVEtDRzUwcUlv?oc=5","date":"2019-04-03","type":"pipeline","source":"labusinessjournal.com","summary":"Soon-Shiong, Nantcell Sued Over Alleged ‘Catch and Kill’ of Cancer Drug - labusinessjournal.com","headline":"Soon-Shiong, Nantcell Sued Over Alleged ‘Catch and Kill’ of Cancer Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5ldEJfaWRIdFZod1dyV2VwSkRlTGpTOEsyaFJJOEloYmxMcjk5cm1XRF9zUFdOUkhHSE1ZcTh5Sl9sUVdjLUhoVWVJam1CVExNLXd4SER0UEU5V00wd3Fqb2plWmNjTEc3S2YtdlFvbEp0dk5McEpJb05n?oc=5","date":"2017-10-19","type":"pipeline","source":"Nanalyze","summary":"11 of Dr. Soon-Shiong’s “Nant” Companies - Nanalyze","headline":"11 of Dr. Soon-Shiong’s “Nant” Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxORTFJcHdQZTRUMzJ5RlpQVXdwdW9zeWE4V1liYlFwUEJBOWR3STBhV0R5U2Y1WkZnVmZRZ01oeUkwblhEU1pLb2VhaVNpWUlTZUtESmRqSktUUDBRX2pUSEVqZnVJXzFKQ0pOS2pFVzlIVUdpSU9HaUN5U2lZNjRqaW1fYWhpUF85Q3Q4SVhMbEpnZDJkY0NMSkdVZEl6STcxb0pkUERQbw?oc=5","date":"2017-10-17","type":"deal","source":"PR Newswire","summary":"NantWorks Acquires Cynviloq™ For Up To $1.3+ Billion - PR Newswire","headline":"NantWorks Acquires Cynviloq™ For Up To $1.3+ Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNRkk5RGdxQllxMzNxenB3M1BoWXh5TzVKdzBaTGZUVGJIOVA3UzhqdngwSnkxVjJ1OTJMNlFtOHJiNWVta2c2aWJOcDFwZHVLYVItZlBOempjWlozMXp0R2ZOdkVsclZPb1EwTmNoMEJjNVlaWXREMHBHQUQ1eGVNTUxPcHRiMXRIYnJub2RIa1dWV2U5bWY3MkJjNU0yUlU1UXJtQ3NBQWRrLUNu?oc=5","date":"2017-07-28","type":"deal","source":"Fierce Biotech","summary":"Soon-Shiong’s NantCell in $356M deal for underperforming CytRx cancer drug - Fierce Biotech","headline":"Soon-Shiong’s NantCell in $356M deal for underperforming CytRx cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTkEwc0RwU0dWNVRPRk5FSjFSVWd3QVhLWEczdmtWdDVKQ3JpeUpOc2JXWTMxVXk3cG11ckx3SFRFaEZLS2IxY1p0MWlBT2JDazVJQ3BhOEQ3ckF6Q0RhTktKS1FfOVVyaDI4c2dXZFROZWo3aTJTV3E4S0gyMzlhMzhEQmZaZ1RrQ1JyRzhyMncwLXNlS2gwenQxdVdtQW1pR0liUG42UzdiQQ?oc=5","date":"2017-06-27","type":"deal","source":"Fierce Biotech","summary":"Despite 'looting' claims, Soon-Shiong’s NantCell to buy Altor - Fierce Biotech","headline":"Despite 'looting' claims, Soon-Shiong’s NantCell to buy Altor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBtNW1SdzFkb3RiRFVfWU5PS25uMlNueEpyZjRZdmxJM2Z5UExfSkZKbFBDWnFXbFlIcXIyaHdpVWkxTFFRMldLMS1aMC1LZ2wwcUpNNmxiQ2lpUHNqTk8teWNBN2hOd19nMlAwdGljZWwyVC01cTBsT25SeG44QQ?oc=5","date":"2017-05-14","type":"pipeline","source":"labusinessjournal.com","summary":"Soon-Shiong Plans Nant IPO - labusinessjournal.com","headline":"Soon-Shiong Plans Nant IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1KNzJTU0JhUXFIX2E2UGdlT1kxVmIwREt3a3ZvUkh4SXF3S0RrXzcxTFFvRlU4NUYySU5xUEI2anEwbHZJZlpqUHJBcVRiUmFwSTN3Mno1dkNQZWU1T3lQaGR5MlAzeUVOLVN0RGxn?oc=5","date":"2015-12-01","type":"pipeline","source":"BioSpace","summary":"What You Need to Know About NantCell - BioSpace","headline":"What You Need to Know About NantCell","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPSU5PSnQ0a1BHSUEzZWVreUJpbDUyWmpDR3hkS1c4VFB5enFSbk1xOERsUXRkYllTMTJrcVlhNkQ2NEVRZERVMjVkdGJPcTgtVjdtN1JPcHp0SmZXSVNocTI4ZW14WndNRGJwcFBvSXQzcXR4RTE2WE5LYnJ4REhVRWNodzlVYjhLc0tn?oc=5","date":"2015-06-23","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Patrick Soon-Shiong’s NantCell Acquires VivaBioCell - Genetic Engineering and Biotechnology News","headline":"Patrick Soon-Shiong’s NantCell Acquires VivaBioCell","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":9,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}